| 4LI5: reference: Structure and Reactivity Based Development of Covalent Inhibitors of the Activating and Gatekeeper Mutant Forms of the Epidermal Growth Factor Receptor (EGFR)., Ward RA, Anderton M, Ashton S, Bethel P, Box M, Butterworth S, Colclough N, Chorley CG, Chuaqui C, Cross D, Debreczeni JE, Eberlein C, Finlay RV, Hill GB, Klinowska TC, Lane C, Martin S, Orme JP, Smith P, Wang F, Waring MJ, Grist M, J Med Chem. 2013 Aug 9. PMID: 23930994 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).